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Background

IVC Filter Implant Patients

Inferior vena cava (IVC) filters are small, cage-like devices placed
percutaneously into the inferior vena cava to prevent propagation of thrombus
into the pulmonary arteries. Currently, there are two available types of filters,
permanent and temporary. Retrievable inferior vena cava (IVC) filter use has
increased over 115% since the Food and Drug Administration (FDA) approval in
2009. Likewise, there has been a marked increase in complications related to
their increased use. In 2014, the FDA initiated a comprehensive analysis of
filter placement and issued the following recommendation: “The FDA
recommends that implanting physicians and clinicians responsible for the
ongoing care of patients with retrievable IVC filters consider removing the filter
as soon as protection from pulmonary embolism is no longer needed.”
Therefore, it is imperative that a hospital system develop a comprehensive
approach to IVC filter placement and follow up to ensure good patient
outcomes and comply with FDA mandates.
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Fig.1
The first year of the IVC Filter Clinic seeing 63 patients

Complications

Parkview Regional Medical Center (PRMC), a tertiary care 440 bed hospital
with approximately 25,000 admissions per year developed a hospital wide
process for following IVC filter patients. An IVC Filter Clinic was created which
allowed for the development of uniform implanting guidelines for filter
placement, consultative services for inpatients, and registry tracking of
patients receiving IVC filters. The registry administrator facilitates a follow-up
appointment in the IVC Filter Clinic where the Physician Director will determine
if and when removal is appropriate. The IVC Filter Clinic started July 1st 2017.

Comments

In the first year, July 2017 through July 2018, the IVC Filter Registry captured
100% of the 63 patients receiving an IVC Filter implant procedure code. Of the
63 patients followed in the registry, 13 were deemed permanent and not
forwarded to the clinic for follow up. Four patients were deceased before the
clinic follow-up appointment and removal of the filter. One patient was
determined to be an outlier with the removal on the start day of the clinic and
no records of the implant. This resulted in 45 patients that were followed by
the clinic in the first year. Seven patients were not seen in the clinic with two
scheduled for removal at the time of implant and the clinic visit was not
needed. Four patients were lost to follow-up despite multiple attempts by staﬀ
to reach them (91.5% scheduled for a visit made it to the clinic appointment
(Continued)
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IVC Filter Dwell time decreased within the 1st 6
months of initiation of the clinic and continued to
drop in the 2nd 6 months.

Poor long-term prognosis

Methods
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and 100% were scheduled initially). There were two unsuccessful removals.
One filter protrusion noted during a cardiovascular surgery was rendered
permanent. All three were included in the clinic numbers since they were seen
in the clinic. The average device dwell time for the group was 78.2 days with a
median of 61 days. In the two years before the clinic started, 128 filters were
placed at PRMC at a rate of 0.55% of total hospital patient volume, compared
to a rate of 0.24% after the initiation of the IVC Filter Clinic, related to a
reduction in “soft” implant indications. All filters were successfully tracked
and 82% were removed compared to the national average of 30%. The
indication for IVC Filter implantation for men was highest in pulmonary
embolism prophylaxis at 24.4%. The indication for women was highest for
acute venous thromboembolism and the inability to anticoagulate at 33.3%.
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Demographics for the 45 patients that had
device removal

Conclusions
Parkview Regional Medical Center has demonstrated the feasibility of a
hospital-based IVC Filter Clinic and registry in a large volume tertiary care
center. We were able to establish that this process resulted in approximately a
50% reduction in filter use. Additionally, all filter patients were able to be
tracked with 91% seen in follow-up and a removal rate of 82%. This uniform
hospital process has resulted in compliance with FDA mandates, better
patient outcomes and system reductions in legal liability.
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